Predictors of Nonuse of a High‐Potency Statin After an Acute Coronary Syndrome: Insights From the Stabilization of Plaques Using Darapladib‐Thrombolysis in Myocardial Infarction 52 (SOLID‐TIMI 52) Trial

BACKGROUND: High‐potency statins reduce cardiovascular events after acute coronary syndromes but remain underused in clinical practice. We examined predictors of nonuse of high‐potency statins after acute coronary syndromes. METHODS AND RESULTS: The Stabilization of pLaques usIng Darapladib‐Thrombol...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Am Heart Assoc
Autors principals: Eisen, Alon, Cannon, Christopher P., Braunwald, Eugene, Steen, Dylan L., Zhou, Jing, Goodrich, Erica L., Im, KyungAh, Dalby, Anthony J., Spinar, Jindrich, Daga, Shruti, Lukas, Mary Ann, O'Donoghue, Michelle L.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2017
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5523629/
https://ncbi.nlm.nih.gov/pubmed/28077384
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.116.004332
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars